Press Releases

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease and the New York Academy of Sciences today convened representatives from industry, academia, government and nonprofits to launch the development of a Global Alzheimer’s Platform (GAP),

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease today announced that Home Instead Senior Care© – the world's leading provider of in-home care services for seniors will join the CEOi to advance the quality of care for those suffering fro

WASHINGTON, DC – The Global CEO Initiative (CEOi) on Alzheimer’s Disease today announced that Takeda Pharmaceutical Company Limited ("Takeda") will join the CEOi as part of its effort to spur innovations in research and accelerate a means of prevention for Alzheimer’s and Dementia, building momentum behind the G8’s com

USAgainstAlzheimer’s Applauds New Alzheimer’s Research Funding through Accelerating Medicines Partnership (AMP)

USAgainstAlzheimer’s will seek to advance the research goals of AMP as a member of the initiative’s steering committee

FY15 BUDGET PROPOSAL FALLS SHORT ON ALZHEIMER'S

USAgainstAlzheimer’s disappointed by failure of the Administration to recommend funding at levels needed to achieve national goal of stopping Alzheimer’s disease by 2025

Pages

^ Back to Top